Results 11 to 20 of about 57,017 (303)
European Respiratory Journal, 2018 Patient-centred outcomes are significantly modified by long-term home noninvasive ventilation (NIV), but a short, self-administered, specific tool for routine clinical assessment is lacking.
E. Dupuis-Lozeron +9 more
semanticscholar +2 more sources
Journal of Mechanical Ventilation, 2021 Non-invasive ventilation use in acute COPD exacerbation and acute respiratory failure is very strong, however the evidence beyond home non-invasive ventilation for COPD patients is less clear.
Kimiyo Yamasaki
doaj +1 more source
Critical Care Innovations, 2021 The management of respiratory failure during the present pandemic has been a challenging issue for the intensivists. There have been few case series and case reports on myasthenic crisis precipitated by severe acute respiratory syndrome coronavirus-2 ...
Mohd Mustahsin +2 more
doaj +1 more source
bioRxiv, 2021 Nipah virus (NiV) is a highly pathogenic and re-emerging virus which causes sporadic but severe infections in humans. Currently, no vaccines against NiV have been approved.
N. van Doremalen +12 more
semanticscholar +1 more source
An outbreak of influenza A(H3N2) in Alappuzha district, Kerala, India, in 2011
Journal of Infection in Developing Countries, 2015 Introduction: Influenza is an RNA virus that belongs to the Orthomyxoviridae family. It causes a highly contagious acute respiratory illness, has been recognized since ancient times, and is a major health threat throughout the world.
Sam Peter +4 more
doaj +1 more source
NIV at home: resource implications [PDF]
Thorax, 2003 The NHS Modernisation Agency’s critical care programme report “Weaning and long term ventilation”1 recommends that long term non-invasive ventilation (NIV) should be available “according to need” and that this service should increase in line with demand. This need has not been well described.
L, Turner +5 more
openaire +2 more sources
European Clinical Respiratory Journal, 2020 Introduction Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has presented health-care systems worldwide with novel challenges and experiences and evidence is emerging during the pandemic. Patients requiring hospitalization frequently suffer
Klaus Nielsen Jeschke +6 more
doaj +1 more source
Immune Response to SARS-CoV-2 Vaccines
Biomedicines, 2022 COVID-19 vaccines have been developed to confer immunity against the SARS-CoV-2 infection. Prior to the pandemic of COVID-19 which started in March 2020, there was a well-established understanding about the structure and pathogenesis of previously known ...
Navya Bellamkonda +5 more
doaj +1 more source
COVID-19: community CPAP and NIV should be stopped unless medically necessary to support life
Thorax, 2020 Dear Editor, Data from the severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) outbreak suggest high viral load at the time of transmission is associated with worse clinical outcomes.1 Non-invasive ventilation (NIV), including CPAP, is ...
Joseph Barker +4 more
semanticscholar +1 more source